Zobrazeno 1 - 3
of 3
pro vyhledávání: '"human CD141+ DCs"'
Autor:
Jing Huang, Jing Zhou, Reem Ghinnagow, Toshiyuki Seki, Sho Iketani, Daphnée Soulard, Patrick Paczkowski, Yukiko Tsuji, Sean MacKay, Luis Javier Cruz, François Trottein, Moriya Tsuji
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Active co-delivery of tumor antigens (Ag) and α-galactosylceramide (α-GalCer), a potent agonist for invariant Natural Killer T (iNKT) cells, to cross-priming CD8α+ dendritic cells (DCs) was previously shown to promote strong anti-tumor responses i
Externí odkaz:
https://doaj.org/article/ffeb8cc1b5fd4df79bb0bfcfd758333e
Autor:
François Trottein, Reem Ghinnagow, Sho Iketani, Daphnée Soulard, Jing Huang, Sean Mackay, Jing Zhou, Yukiko Tsuji, Moriya Tsuji, Patrick Paczkowski, Luis J. Cruz, Toshiyuki Seki
Publikováno v:
Frontiers in Immunology, 11. FRONTIERS MEDIA SA
Frontiers in Immunology
Frontiers in Immunology, 2020, 11, pp.2043. ⟨10.3389/fimmu.2020.02043⟩
Frontiers in Immunology, Frontiers, 2020, 11, pp.2043. ⟨10.3389/fimmu.2020.02043⟩
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology, 2020, 11, pp.2043. ⟨10.3389/fimmu.2020.02043⟩
Frontiers in Immunology, Frontiers, 2020, 11, pp.2043. ⟨10.3389/fimmu.2020.02043⟩
Frontiers in Immunology, Vol 11 (2020)
Active co-delivery of tumor antigens (Ag) and alpha-galactosylceramide (alpha-GalCer), a potent agonist for invariant Natural Killer T (iNKT) cells, to cross-priming CD8 alpha(+) dendritic cells (DCs) was previously shown to promote strong anti-tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da61d6a3cbe282ae349622d7862a40ce
http://hdl.handle.net/1887/3184215
http://hdl.handle.net/1887/3184215
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.